← Back to Search

Covid-19 vaccine education materials for Covid-19 Vaccine (PROCOVAXED Trial)

N/A

Waitlist Available

Led By Robert Rodriguez, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up within 6 hours of intervention

Awards & highlights

PROCOVAXED Trial Summary

This trial will test whether informational platforms that address barriers to COVID-19 and influenza vaccination can increase vaccine acceptance and uptake in vulnerable populations whose primary health care access occurs in emergency departments.

Eligible Conditions

Covid-19 Vaccine
Vaccine Hesitancy

PROCOVAXED Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ within 6 hours of intervention

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~within 6 hours of intervention

This trial's timeline: 3 weeks for screening, Varies for treatment, and within 6 hours of intervention for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Covid-19 Vaccine Acceptance in the Emergency Department: PROCOVAXED

Covid-19 Vaccine Uptake: PROCOVAXED

PROCOVAXED Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Intervention Arm: PROCOVAXEDExperimental Treatment1 Intervention

Covid vaccine educational intervention consisting of vaccine messaging platforms (flyers, videos, scripted face-to-face messaging)

Group II: Non-interventional Arm: PROCOVAXEDActive Control1 Intervention

Usual care

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of WashingtonOTHER

1,743 Previous Clinical Trials

1,847,329 Total Patients Enrolled

National Institute of Allergy and Infectious Diseases (NIAID)NIH

3,270 Previous Clinical Trials

5,484,696 Total Patients Enrolled

University of California, San FranciscoLead Sponsor

2,507 Previous Clinical Trials

15,237,999 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any remaining positions open to participants in this experiment?

"Affirmative. The information available on clinicaltrials.gov indicates that this research endeavor, which was first uploaded on December 6th 2021, is actively recruiting participants. A total of 1290 patients are needed across 8 different medical centres to complete the trial."

Answered by AI

How many people have signed up to participate in this investigation?

"In order to be successful, this medical study requires 1290 patients who fulfil the inclusion criteria. Participants can access the trial through multiple sites such as Jefferson Torresdale Hospital in Philadelphia and Duke University Hospital in Durham."

Answered by AI

At what sites can patients access this clinical trial?

"This clinical trial is administered across 11 sites, including Philadelphia, Durham and Seattle. It would be wise to pick the closest location in order to reduce any travelling requirements should you choose to enrol."

Answered by AI

Recent research and studies

TrialsJournal

Promotion of Covid-19 Va(x)ccination in the Emergency Department—procovaxed: Study Protocol for a Cluster Randomized Controlled Trial

Rodriguez, Robert M., Kelli O’Laughlin, Stephanie A. Eucker, Anna Marie Chang, Kristin L. Rising, Graham Nichol, Alena Pauley, et al.. 2022. “Promotion of Covid-19 Va(x)ccination in the Emergency Department—procovaxed: Study Protocol for a Cluster Randomized Controlled Trial”. Trials. Springer Science and Business Media LLC. doi:10.1186/s13063-022-06285-x.

clinicaltrials.govStudy

PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED

2021. "PROmotion of COvid-19 VA(X)Ccination in the Emergency Department - PROCOVAXED". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05142332.